Biological And Psychological Health Indices Of Ecstasy/polydrug Users: Testing The Bioenergetic Stress Model
Funder
National Health and Medical Research Council
Funding Amount
$344,015.00
Summary
Use of Ecstasy is increasing in both Australia and the United Kingdom, and is related to poorer psychological and mental functioning in the long-term, suggesting Ecstasy use negatively impacts human physiology producing deficits in aspects of mental functioning. This project aims to assess the effect of weekend use and lifetime use of ecstasy upon measures of physiology and psychology. Findings from these studies may contribute to strategies to reduce the harm associated with Ecstasy use.
Ecstasy use is growing faster throughout the world than than any other drug of abuse. United Nations figures from 2003 show that it is used by more individuals than the combined total of cocaine and heroin users. Australia has the highest per capita use of 'Ecstasy' in the world with rates twice those of North Americal and Europe. As a result of this we also have a high rate of adverse effects. These can be immediate, and lead to death, or long term leading to brain damage and psychopathologies. ....Ecstasy use is growing faster throughout the world than than any other drug of abuse. United Nations figures from 2003 show that it is used by more individuals than the combined total of cocaine and heroin users. Australia has the highest per capita use of 'Ecstasy' in the world with rates twice those of North Americal and Europe. As a result of this we also have a high rate of adverse effects. These can be immediate, and lead to death, or long term leading to brain damage and psychopathologies. So far, no studies have been conducted,anywhere in the world, which have objectively examined the medical effects of 'ecstasy' in the dance clubs where it is used. Because of this, there is a lot of speculation on whether the animal based or hospital based studies are valid and relate to normal recreational use of this drug. This has led to a degree of suspicion by users and health professionals as to the medical problems claimed to be associated with the drug. This project extends a pilot study we undertook which has highlighted that in a recreational setting it is likely that specific individuals are susceptible to damage by 'ecstasy'. The purpose of this project is to examine this in detail, and identify who, and why some young persons are at risk of immediate life threatening outcomes from 'ecstasy' use or may develop brain damage later. The intended outcome is to provide clear evidence of adverse effects and why they occur. This evidence may be used to improve harm minimisation and treatment programs.Read moreRead less
The Role Of Neuropeptides In The Acute And Long-term Effects Of MDMA, Methamphetamine And GHB
Funder
National Health and Medical Research Council
Funding Amount
$472,321.00
Summary
The widespread use of 'party drugs' (ecstasy, methamphetmaine and GHB) is a major health issue in Australia. We propose a novel hypothesis that key acute and long-term effects of these drugs may involve an action on the neuropeptide oxytocin. A number of experiments are planned to test this hypothesis. The findings from this project will be used to better understand and to explore novel treatments for people who suffer problems as a result of using these drugs.
Brain And Skin Blood Flow: New Animal Model For Understanding Psychiatric Disorders And Evaluating Psychotropic Agents
Funder
National Health and Medical Research Council
Funding Amount
$874,840.00
Summary
We suddenly become pale when we get a fright; cutaneous blood vessels are linked to psychological function. The skin vessel constriction response occurs because special neurochemical pathways in the brain send messages to the spinal cord, and from there messages traverse peripheral sympathetic nerves to constrict the blood vessels in the skin. By measuring skin blood flow in the rabbit ear and the rat tail we have been able to discover the major brain pathway by which the constrict-the-skin-bloo ....We suddenly become pale when we get a fright; cutaneous blood vessels are linked to psychological function. The skin vessel constriction response occurs because special neurochemical pathways in the brain send messages to the spinal cord, and from there messages traverse peripheral sympathetic nerves to constrict the blood vessels in the skin. By measuring skin blood flow in the rabbit ear and the rat tail we have been able to discover the major brain pathway by which the constrict-the-skin-blood-vessels message reaches the spinal cord. The pathway involves the amygdala, a forebrain region important in emotional expression and the raphe nuclei in the medulla oblongata. Drugs which affect psychological function also effect skin blood flow. Ecstasy, the street drug used to induce euphoria also constricts the skin vessels, and, sadly, the body temperature may increase so much that death ensues. Ecstasy vigorously constricts the skin blood vessels in rabbits, and temperature increases. Ecstasy is thought to act on serotonin-containing nerve cells in the brain, releasing serotonin (5-HT) onto special 5-HT2A receptors. Activation of these receptors affects both psychological function and skin blood flow. Modern drugs used to treat schizophrenia, so called atypical antipsychotics like clozapine and olanzapine, are thought to act as antagonists at 5-HT2A receptors in the brain. We were thus very excited when we discovered in our rabbit model that clozapine reverses the skin vasoconstriction induced by ecstasy. This means that we have specific hypotheses concerning the actual brain pathways and neurotransmitters whereby ecstasy and clozapine exert their effects on skin blood flow. Elucidating these pathways in rabbits and rats will provide solid knowledge concerning the mechanism of action of the atypical antipsychotics, and it may well prove possible to use our animal model to predict whether proposed new antipsychotic agents will be therapeutically effective.Read moreRead less
The Ecstasy Check-Up: A Multi-site Trial Of A Brief Intervention For Ecstasy Use Among Regular Ecstasy Users
Funder
National Health and Medical Research Council
Funding Amount
$458,432.00
Summary
Rates of ecstasy use have continued to rise rapidly over the past 10-15 years, particularly among young people. This is of concern, as several studies indicate that ecstasy is associated with a range of short- and long-term harms. Although many users acknowledge risks associated with ecstasy use, few users seek treatment. Therefore, the current project will aim to reduce ecstasy use and harm by providing non-treatment seeking ecstasy users with a brief motivational intervention.